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Obesity is associated with chronic low-grade inflam-
mation that negatively impacts insulin sensitivity.
Here, we show that high-fat diet can increase
NF-kB activation in mice, which leads to a sustained
elevation in level of IkB kinase 3 (IKK3) in liver,
adipocytes, and adipose tissue macrophages. IKK3
knockout mice are protected from high-fat diet-
induced obesity, chronic inflammation in liver and
fat, hepatic steatosis, and whole-body insulin resis-
tance. These mice show increased energy expendi-
ture and thermogenesis via enhanced expression
of the uncoupling protein UCP1. They maintain
insulin sensitivity in liver and fat, without activation
of the proinflammatory JNK pathway. Gene expres-
sion analyses indicate that IKK3 knockout reduces
expression of inflammatory cytokines, and changes
expression of certain regulatory proteins and en-
zymes involved in glucose and lipid metabolism.
Thus, IKK3 may represent an attractive therapeutic
target for obesity, insulin resistance, diabetes, and
other complications associatedwith these disorders.
INTRODUCTION
Numerous longitudinal studies suggest that insulin resistance is
the first step in the development of Type 2 diabetes, particularly
in obese patients (Saltiel, 2001; Taniguchi et al., 2006; Thirone
et al., 2006). Obesity produces a state of chronic low-grade
inflammation, accompanied by increased circulating levels of
proinflammatory cytokines (Hotamisligil, 2006; Shoelson et al.,2007; Wellen and Hotamisligil, 2005). Many of these cytokines
can block insulin action, and knockout of some inflammatory
genes disrupts the link between dietary or genetic obesity and
insulin resistance (Hotamisligil, 2006; Shoelson et al., 2007).
Many studies have indicated a role for NF-kB (Tilg andMoschen,
2008; Wunderlich et al., 2008). This pathway may be activated
by the toll-like receptor-4 (TLR4) due to interactions with
dietary fatty acids (Kim et al., 2007; Tsukumo et al., 2007), or
as a consequence of hypoxia (Schenk et al., 2008; Ye et al.,
2007). Targeted deletion (Arkan et al., 2005; Cai et al., 2005;
Zhang et al., 2008) or pharmacological inhibition (Yin et al.,
1998; Yuan et al., 2001) of the kinase IKKb, which lies upstream
of the inhibitory IkB proteins, can restore insulin sensitivity in
obese mice or humans.
Despite strong evidence for an inflammatory link between
obesity and diabetes, the primary site or sites at which the
inflammatory response occurs has not yet been established.
Adipose tissue responds to overnutrition by secreting cyto-
kines or chemokines that recruit proinflammatory, M1 polar-
ized macrophages to adipose tissue (Lumeng et al., 2007b).
These in turn secrete more cytokines that attenuate insulin
action in adipocytes, resulting in increased lipolysis and free
fatty acid release (Feingold et al., 1992; Green et al., 1994).
However, the molecular details underlying macrophage recruit-
ment and activation, the subtypes involved, their crosstalk
with muscle, fat and liver cells, and the manner by which
they regulate energy expenditure and storage remain uncer-
tain. Here, we report that high-fat diet induces the expression
of the NF-kB target IKK3 in both liver and white adipose tissue,
and further that mice bearing a targeted deletion of IKK3 are
surprisingly protected from diet-induced obesity, liver and
adipose inflammation, hepatic steatosis, and insulin resistance,
providing an appealing therapeutic target for obesity and type
2 diabetes.Cell 138, 961–975, September 4, 2009 ª2009 Elsevier Inc. 961
RESULTS
High-Fat Diet Produces the Activation
of NF-kB in Transgenic Mice
While NF-kB activation has been implicated in obesity, the range
of tissues involved is unknown. We analyzed the effect of diet-
induced obesity (DIO) on transgenic mice engineered with a
luciferase construct driven by an NF-kB-responsive promoter
(HLL mice) (Sadikot et al., 2001). After injection with a luciferin
substrate, high-fat diet (HFD)-fed HLL mice demonstrated
an approximate 2-fold increase in abdominal luminescence
compared to chow-fed controls (Figure 1A). The reporter was
activated 5-fold in subcutaneous and visceral adipose tissue
after HFD; this activation persisted after correction for tissue
weight (Figures 1B, 1C, and Figure S1A available with this article
online). Less pronounced transgene activation was seen in the
liver, kidney and quadriceps muscle. Surprisingly, NF-kB trans-
gene activation was similar in both subcutaneous and visceral
fat depots, suggesting that the documented inflammatory differ-
ences between these depots may be independent of NF-kB.
It has been proposed that obesity-induced inflammation is
chronic and low-grade compared to other inflammatory stimuli
(Hotamisligil, 2006; Shoelson et al., 2007; Wellen and Hotamisli-
gil, 2005). We compared the degree of NF-kB activation in
normal chow and HFD HLL mice before and after injection with
lipopolysaccharide (LPS) (Figure S1B). For all tissues examined
(except muscle), LPS injection activated the transgene far above
basal levels, supporting the notion that NF-kB activation is sub-
maximally but chronically activated in obesity.
We performed immunohistochemical analyses in adipose
tissue of HLLmice on control andHFD (Figure 1D). The luciferase
reporter was specifically enriched in adipose tissue macrophage
(ATM) clusters and adipocytes in epididymal fat pads from only
HFD mice. NF-kB expression (RelA/p65) was also more concen-
trated in the nuclei of F4/80+ ATM clusters by immunofluores-
cence in HFD mice, while the protein remained cytoplasmic in
macrophages from chow-fed mice (Figure 1E).
High-Fat Diet Increases IKK3 Expression in White
Adipose Tissue and Liver
Wemeasured the expression of the gene encoding the inducible
IKK family member IKK3 in liver and white adipose tissue by real-
time PCR and then compared this to the levels of other IKKs.
HFD produced a small increase in the expression of IKKa, b,
and TBK1 in liver, but it produced a 2.6-fold increase in IKK3
mRNA (Figure 2A). In white adipose tissue (WAT), IKKa was
slightly reduced, whereas HFD increased IKKb 1.7-fold, and
IKK3 and TBK1 by 12- and 9-fold, respectively. To determine
the cell types in adipose tissue responsible for these changes,
we separated by centrifugation adipocytes from the SVF. HFD
produced a 2- to 3-fold increase in expression of IKKa, IKKb
and TBK1 mRNA in adipocytes, whereas IKK3 expression was
increased up to 28-fold (Figure 2B). However, only IKK3 was
upregulated in SVF isolated from WAT, although the number of
macrophages in adipose tissue was also significantly increased
(Weisberg et al., 2003; Xu et al., 2003).
We also performed immunohistochemistry by confocal
microscopy (Lumeng et al., 2007b). WAT from control diet-fed962 Cell 138, 961–975, September 4, 2009 ª2009 Elsevier Inc.mice exhibited M2 polarized, MGL1+ ATMs (Lumeng et al.,
2007a), whereas HFD produced increased infiltration of M1
polarized, MGL1- macrophages, detected in crown-like struc-
tures (Figure 2C). While IKK3 was barely detected in adipose
tissue from control mice, the protein was observed in adipocytes
and MGL1-, F4/80+, but not MGL1+ ATMs in adipose tissue from
HFD mice. Thus, HFD induction of IKK3 occurred mainly in M1,
but not M2-polarized ATMs, although it remains uncertain
whether diet produces an increase in expression of the kinase
in proinflammatory M1 ATMs or rather reflects the different acti-
vation state of these cells.
We also monitored IKK3 protein levels by western blotting
(Figure 2D). IKK3 expression was low in liver or WAT from wild-
type mice on a chow diet, but was markedly increased in both
tissues after HFD, correlating well with RNA levels. Interestingly,
none of the other IKK isoforms were upregulated in IKK3 KO
mice, suggesting that no compensation occurred (Table S1).
IKK3 kinase activity increased by 3.7-fold and 1.5-fold in liver
and WAT from HFD mice (Figure 2E). Treatment of COS cells
overexpressing IKK3 with LPS produced a time-dependent
increase in activity (Supplementary Figure 2).
IKK3 Knockout Mice Display Decreased Weight Gain
and Increased Energy Expenditure on a High-Fat Diet
The increased expression of IKK3 after HFD led us to wonder
if this protein represented a link between obesity and insulin
resistance. We therefore evaluated mice with a targeted deletion
in the IKK3 gene (Tenoever et al., 2007). On normal chow,
weights, circulating levels of glucose and non-esterified fatty
acids did not differ significantly between IKK3 KO mice and
their wild-type counterparts, although triglycerides were lower
and fasting insulin levels slightly higher in KO mice (Table 1).
However, after exposure for 3 months to HFD, wild-type controls
gained near 20 g, whereas IKK3 KO mice gained only 12 g
(Figures 3A and S3). Body weight and percentage of lean and
fat mass was similar between wild-type and IKK3 KO mice on
chow (Table S2). HFD increased lean and fat mass in wild-type
mice, with a statistically smaller increase in KO mice. HFD
produced a large increase in liver weight in control but not in
KO mice (Figure S4). Adipocytes from IKK3 KOmice were signif-
icantly smaller than those from wild-type mice on HFD (Figures
3B and 3C), although there was a 10%–15% increase in the
number of cells in the epididymal fat pad (Figure 3D). Together
these data suggest that deletion of the IKK3 gene prevents the
increase in liver mass induced by high-fat diet, and maintains
adipose tissue mass by increasing adipogenesis, reflected by
more, smaller fat cells.
While no differences were detected inmice on a chow diet, the
serum adiponectin levels were significantly higher in KO mice on
HFD compared to wild-type controls (Figure S5A). As previously
reported (Kadowaki et al., 2006), adiponectin levels per body
weight were decreased by approximately 33% in wild-type
mice after HFD. Interestingly, this HFD-induced decrease was
almost completely prevented in IKK3 KO mice. HFD increased
serum leptin levels by 8.5-fold in wild-type mice (Figure S5B),
while leptin levels were approximately 40% lower in IKK3 KO
mice exposed to normal chow or HFD, probably reflecting
smaller adipocyte size and increased leptin sensitivity.
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Figure 1. HFD Increases NF-kB Activity in Adipose Tissue Measured by In Vivo Bioluminescence in Live Mice
(A) Male HLLmice on normal diet (ND) and HFD were assessed for bioluminescence after injection of luciferin. Luminescence was collected from a gate limited to
the abdominal cavity is presented for ND and HFD HLL mice. (n = 7 per group). *p value < 0.05.
(B) Tissues from HLL mice were dissected and assessed ex vivo for luminescence. Epididymal white adipose tissue (Epi WAT).
(C) Quantitation of absolute tissue luminescence from HLL mice. n = 7 per group. Data was collected serially after dissection to ensure plateau of luminescent
signal.
(D) Immunohistochemical localization of luciferase expression in epididymal fat pads from HLL mouse fed with normal and high-fat diet.
(E) Epididymal fat pads from ND or HFD fed male mice were analyzed for p65/RelA expression by immunofluorescence showing maximal signal concentration of
p65/RelA in ATM clusters and localization of p65 in ATM nuclei (TOPRO3 as nuclear marker). The scale bar represents 20 mm.Cell 138, 961–975, September 4, 2009 ª2009 Elsevier Inc. 963
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Figure 2. HFD Increases IKK3 Expression in White Adipose Tissue and Liver
(A) qPCR analysis on the expression of genes encoding IKK family members in liver and white adipose tissue. White bars, wild-type mice, normal diet (ND) (n = 6);
gray bar, wild-type mice, high-fat diet (HFD) for 4 months (n = 6). All data are presented as the average ± SEM normalized to Rplp0 expression. Average of ND
value was set as 1.
(B) qPCR analysis on the expression of genes encoding IKK family members in isolated adipocytes and stromal vascular fraction. White bars, ND (n = 6); gray bar,
HFD for 4 months (n = 6).
(C) (Top) confocal merged images from epididymal fat pads from ND and HFD-fed mice co-stained with anti-IKK3 (green), anti-MGL1 (red) and anti-Caveolin1
(blue) antibodies. Representative image shown and similar results from 3-4 independent mice. (Bottom) confocal images from epididymal fat pads from HFD-
fed wild-type mice immunostained with anti-IKK3 antibody (green), anti-F4/80 antibody (red) or merged image with anti-caveolin 1 antibody (blue). The scale
bar represents 50 mm.
(D) Lysates from liver and white adipose tissue (WAT) of wild-type (WT) and IKK3 knockout mice (IKK3 KO) fed with ND or HFD were immunoprecipitated with
antibody against IKK3 as indicated. The expression level of IKK3 was determined by immunoblotting with same antibody against IKK3.
(E) Lysates from liver and WAT of WT and IKK3 KO fed with ND or HFD were immunoprecipitated (IP) with antibody against IKK3 and assayed for kinase activity
against myelin basic protein (MBP) as substrate. The expression level of IKK3 in IP was determined by immunoblotting with same antibody against IKK3. Lysates
for IP were immunoblotted with antibodies against Rab5B and Caveolin 1 as a loading control.964 Cell 138, 961–975, September 4, 2009 ª2009 Elsevier Inc.
Body weight represents a net balance of food intake and
energy expenditure. IKK3 KO mice showed higher daily food
intake per body weight compared to wild-type mice, either on
chow or HFD (Figure 3E), perhaps due to lower circulating
leptin levels. O2 consumption was similar in both wild-type and
IKK3 KO mice on a chow diet (Figure 3F). Wild-type mice on
HFD showed little change in O2 consumption, whereas IKK3
KO mice demonstrated a significant increase. This difference
was consistent throughout light and dark phases, indicating an
increase in energy expenditure. We also compared the respira-
tory quotient (RQ = VCO2/VO2), as a measure of fuel-partitioning
patterns. RQ fluctuated between 0.85 and 1.0 in mice on a chow
diet, and fluctuated between 0.8 and 0.9 in mice on HFD for both
genotypes (Figure 3G).
The lack of effect of IKK3 KO on RQ suggested that there
was no difference in fuel selection between carbohydrates and
lipids, leading us to explore whether the increase in energy
expenditure might occur secondarily to increased thermogene-
sis, and we thus evaluated the expression of uncoupling proteins
(Figure 3H). In chow-fed mice, UCP1 mRNA was barely detect-
able in WAT from wild-type or IKK3 KO mice. HFD produced
a 2-fold increase in UCP1 mRNA in wild-type mice, but gener-
ated a 10-fold increase in KO mice. UCP1 protein levels in
WAT of KO mice on HFD were similarly higher. The expression
of UCP2 was similar between wild-type and KO mice on either
diet (Figure S6A), and UCP1 mRNA and protein levels in brown
fat were unchanged (Figure S6B). A significant increase in
body temperature was also noted in IKK3 KO mice (Figure 3I).
IKK3 KO mice were 1.5C warmer than their wild-type counter-
parts on HFD, with a smaller 0.5C increase seen under chow-
fed conditions. However, there was no apparent increase in
the expression of mitochondrial biogenesis proteins in muscle,
WAT or BAT in IKK3 KO mice (Figure S6C).
Konckout of IKK3 Improves Glucose and Lipid
Homeostasis
Because IKK3 KO mice were protected from DIO, we investi-
gated whether this gene might play a role in glucose homeo-
stasis. As mentioned above, chronic exposure to HFD increased
fasting glucose and insulin levels in wild-type but not KO mice
(Figure 4A). IKK3 KO mice exhibited reduced fasting serum free
fatty acid and cholesterol levels on HFD (Figure 4B), but were
similar to wild-types regarding fasting serum triglyceride levels.
We performed intraperitoneal (IP) glucose and insulin toler-
ance tests after 3 months of chow or HFD (Figures 4C and 4D).
While wild-type mice were glucose intolerant on HFD, IKK3 KO
Table 1. Metabolic Parameters ofWild-Type and IKK3-KOMice in
Normal Diet
Parameters Wild-Type IKK3 KO P Value
Body weight (g) 32.02 ± 0.90 32.71 ± 0.58 0.525
Glucose (mg/dL) 159.3 ± 5.2 144.0 ± 11.2 0.26
Insulin (pg/ml) 619.3 ± 89.2 916.4 ± 96.2 0.051
NEFA (mM) 0.969 ± 0.077 0.840 ± 0.037 0.175
Triglyceride (mg/dL) 50.39 ± 3.13 40.49 ± 2.31 0.03*
Cholesterol (mg/dL) 82.5 ± 3.24 78.2 ± 2.02 0.292mice maintained normal glucose tolerance and lower insulin
levels. Although there were no differences detected between
the genotypes on a normal diet, HFD IKK3 KO mice were more
sensitive to IP injection of insulin (Figure 4E) and pyruvate
(Figure 4F) compared to wild-type controls.
IKK3 Knockout Preserves Insulin Signaling
To investigate the mechanisms by which targeted disruption of
the IKK3 gene protects mice from the deleterious effects of
HFD, we investigated insulin signaling in liver, fat and muscle
ex vivo. In liver from both wild-type and IKK3 KO mice fed
a normal chow diet, insulin injection stimulated Akt phosphoryla-
tion (Figure S7A). While HFD produced a blunted insulin
response in wild-type mice (Khamzina et al., 2005), the IKK3
KO mice exhibited normal insulin-stimulated Akt phosphoryla-
tion (Figure 5A). Insulin-stimulated Akt phosphorylation was
similarly reduced in WAT after HFD in wild-type but not KO
mice (Figure 5B), but was similar between genotypes in gastroc-
nemius muscle (Figure 5C). The insulin-stimulated phosphoryla-
tion of the insulin receptor, and levels of IRS-1 were similarly
restored in KO mice in liver and fat, but not muscle (Figure S7B),
suggesting that IKK3may be a local negative regulator of insulin
signaling. Indeed, HFD had no effect on the expression of IKK3 in
muscle (data not shown).
Hepatic gene expression microarray analyses showed signifi-
cant differences between IKK3 KO and wild-type controls on
HFD in levels of mRNA encoding several proteins (Table S3),
including two genes involved in glucose homeostasis, pyruvate
dehydrogenase kinase isoform 4 (PDK4) (Figure 5D) and glucoki-
nase (Figure 5E), with smaller changes in fructose 1,6 bisphos-
phatase and malate dehydrogenase. Interestingly, there was
little if any change observed in pyruvate kinase, PEPCK or
glucose-6-phosphatase mRNAs (Figure S8). The reduction in
PDK4 and increase in glucokinase could produce increased
flux of glucose through glycolysis, and may account for the
improvement in pyruvate tolerance and the reduced level of
free fatty acids observed in IKK3 KO mice.
In addition to direct effects on hepatic gene expression, the
increased hepatic insulin sensitivity in IKK3 KO mice might also
occur secondarily to increased circulating levels of adiponectin,
which correlates inversely with insulin resistance (Kadowaki
et al., 2006). Adiponectin mRNA was reduced in WAT from
HFD wild-type but not KO mice (Figure 5F), correlating well
with circulating levels (Supplementary Figure 5A). Because adi-
ponectin is regulated by the activity of PPARg (Semple et al.,
2006), we also examined whether PPARg expression is induced
in KO mice. PPARg mRNA and protein levels in WAT were
reduced by HFD in wild-type mice, but elevated in IKK3 KO
mice (Figure 5G). The PPARg-regulated genes CD36, CAP and
GLUT4 were also upregulated in adipocytes from these mice,
as were the encoded proteins (Figure 5H), further indicating
that PPARg activity is increased in adipose tissue from these
mice. Recent studies showed that lipin1 directly interacts with
PPARg and increases its transcriptional activity (Koh et al.,
2008). IKK3 KO mice expressed nearly 2-fold greater levels of
lipin1 mRNA and protein compared to control mice on HFD
(Figure S9), providing a clue to the improved insulin responsive-
ness in adipose tissue of the KO mice.Cell 138, 961–975, September 4, 2009 ª2009 Elsevier Inc. 965
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Figure 3. IKK3 KO Mice Are Protected from Diet-Induced Weight Gain by Increasing Energy Expenditure
(A) Representative images of mice from WT and IKK3 KO mice fed with ND or HFD.
(B) Representative confocal image of caveolin-stained epididymal adipose tissue from WT and KO mice fed with HFD. The scale bar represents 100 mm.
(C) Whisker plot of adipocyte area from evaluation of < 500 adipocytes from 3–4 independent mice. *p < 0.0001 comparing mean adipocyte area.
(D) Adipocyte numbers in fat pads of WT (gray bar) and IKK3 KO mice (black bar) fed with HFD. n = 5 mice per genotype. *, p value < 0.005.
(E) Food intake was measured for WT (gray bar) and KO (black bar) mice fed with ND or HFD as indicated. n = 8 mice per group. *, p value < 0.05.
(F) Oxygen consumption (VO2) wasmeasured forWT (orange) and KO (green)mice fedwith ND (top) orWT (red) and KO (blue)mice fedwith HFD (bottom) for three
days as indicated. n = 8 mice per group.966 Cell 138, 961–975, September 4, 2009 ª2009 Elsevier Inc.
Wenextmeasured the insulin sensitivity of isolated adipocytes
in vitro by assaying rates of lipogenesis at low concentrations of
glucose, as a surrogate for glucose transport (Lesniewski et al.,
2007). Adipocytes derived from wild-type mice on a control
diet responded to insulin with 2-fold increase in lipogenesis
(Figure 5I), but those from HFD mice were almost completely
unresponsive to insulin. In contrast, adipocytes isolated from
IKK3 KO mice on HFD remained insulin responsive.
To determine whether the resistance of adipocytes from IKK3
KO mice to the deleterious effects of high-fat diet is cell autono-
mous, we mimicked the HFD-induced expression of IKK3 by
overexpressing the enzyme in 3T3-L1 adipocytes, and then
assayed for insulin-stimulated glucose uptake (Min et al., 1999)
(Figure 5J). Insulin produced a 10-fold increase in glucose
transport in these cells. Transfection of cells with wild-type IKK3
reduced insulin-stimulated glucose uptake by 50%, whereas the
expression of kinase-dead IKK3 mutant produced only a small
inhibitory effect. No significant differences in insulin-stimulated
tyrosine phosphorylation of its receptor or IRS-1 were detected
(Figure S10), suggesting that IKK3 overexpression did not
directly influence this signaling pathway. These data, along
with the changes in the expression of CAP (Ribon et al., 1998)
and GLUT4 (Armoni et al., 2006) in vivo, suggest that increased
expression of IKK3 in adipocytes produces a direct, cell-autono-
mous reduction in insulin sensitivity, potentially through tran-
scriptional regulation.
IKK3 Knockout Mice Are Protected from Diet-Induced
Hepatic Steatosis
Chronic exposure ofmice toHFDcauses enlarged livermass and
accumulation of lipids, leading to fatty liver (steatosis) (Bradbury,
2006; Postic and Girard, 2008). HFD increased liver mass in
wild-type controls but not in IKK3 KO mice (Figure 6A). The
absence of steatosis in KOmice was apparent from examination
of the liver, which was considerably darker than that of the wild-
type counterparts (Figure 6B). The triglyceride content of livers
from IKK3 KO mice was significantly lower than those of wild-
typemice after HFD, either in fed or fasted conditions (Figure 6C).
Additionally, high-fat diet caused abundant macrosteatosis in
wild-type but not KO livers, as visualized by H-E staining (Fig-
ure 6D), correlating well with reduced hepatic triglycerides.
Excessive fat accumulation in the liver can occur as a result of
increased fat delivery or synthesis, reduced oxidation, and/or
reduced fat export in the form of VLDL (Postic and Girard,
2008). Interestingly, we did not detect significant differences
between wild-type and KO mice in the expression of lipogenic
enzymes, including FAS, ACC1, and Scd1, or those involved in
beta-oxidation, including Acox1, Acad1, CPT1a, and MCAD,
although all of these genes showed the expected response tonutritional status (Figure S11). Lipin1 expression reduces
VLDL-triglyceride release from liver (Chen et al., 2008), and its
deficiency is associated with fatty liver and insulin resistance
(Xu et al., 2006). Interestingly, hepatic mRNA and protein levels
of lipin1 were increased in IKK3 KO mice on both control and
HFD (Figure 6E). Moreover, CD36 expression increased in
response to high-fat feeding in wild-type but not KO mice
(Figure 6F). Additionally, the HFD-induced increase in the
expression of both hepatic FABP4 and PPARgwas partially pre-
vented in IKK3 KO mice (Figure 6F). Thus, although it is not
possible to determine which effects were primary or secondary
to reduced lipid accumulation, IKK3 KO mice were protected
from diet-induced hepatic steatosis partially due to direct
inhibition of the expression of CD36, PPARg and FABP4, and
increased expression of Lipin1.
To determine whether increased levels of IKK3 in liver cells can
reproduce the effects of HFD on gene expression in a cell-auton-
omous fashion, we transfected H2-35 hepatoma cells with
wild-type or kinase-inactive IKK3, and assayed mRNA levels
of selected genes by RT-PCR (Figure 6G). Interestingly,
expression of the wild-type kinase produced an approximate
1.5-fold increase in the expression of PDK4 and PPARg, with
a 9-fold increase in Rantes mRNA, 5-fold increase in IP-10 and
3-fold increase in iNOS expression. In contrast, overexpression
of a kinase-dead enzymewaswithout effect. These data suggest
that the IKK3-dependent changes in hepatic gene expression are
likely to be direct and cell autonomous.
IKK3 Knockout Mice Are Protected from Chronic,
Diet-Induced but Not Acute Inflammation
While serum levels of TNF-a, MCP-1, and Rantes were similar
between wild-type controls and KO mice on chow diet
(Figure 7A), HFD elevated the secretion of all three proinflamma-
tory cytokines in wild-type but not KO mice. Adipose tissue from
IKK3 KOmice on HFD exhibited a 90% reduction in ATM infiltra-
tion compared to wild-type controls, as detected with F4/80
antibody (Figures 7B and 7C). The remarkable decrease in
ATM content could conceivably be due to a changed property
of the macrophages, or to altered chemotactic signals from
adipocytes. Knock down of IKK3 had no effect on the response
of RAW264.7 cells to LPS regarding migration. Bone marrow-
derived macrophages from KO mice were also similarly respon-
sive to LPS (Figure S12), indicating that the marked reduction in
MI-polarized ATMs in KO mice was due mainly to a reduction in
chemotactic signals from fat tissue. In this regard, the expres-
sion of mRNAs encoding the chemokines TNF-a, Rantes, and
MIP1a in adipose tissue was also significantly decreased, corre-
lating well with reduced ATM infiltration, although levels of
MCP-1a and IP-10 mRNA were unaffected (Figure 7D).(G) Respiratory quotient (RQ) wasmeasured for WT (orange) and KO (green) mice fed with ND (top) or WT (red) and KO (blue) mice fed with HFD (bottom) for three
days as indicated. n = 8 mice per group.
(H) (Top) qPCR analysis on the expression of genes encoding UCP1 in WAT. Gray bars, wild-type mice (n = 6); black bar, IKK3 KOmice (n = 6) fed with ND or HFD
as indicated. All data are presented as the average ± SEM normalized to Rplp0 expression. *, p value < 0.05. Average of WT fed with ND value was set as 1.
(Bottom) Protein expression of UCP1 in WAT, measured by immunoblotting with WAT lysates from WT and IKK3 KO mice (5 mice in each group) fed with
HFD as indicated. Rab5 was used as internal loading control.
(I) Rectal temperature measured for WT and KOmice fed with ND (3 months old) or HFD (5 months old with diet for 2 months). n = 10 per group. *, p value < 0.05;
**, p value < 0.01.Cell 138, 961–975, September 4, 2009 ª2009 Elsevier Inc. 967
A0
50
100
150
200
250
ND HFD
B
l
o
o
d
 
g
l
u
c
o
s
e
 
(
m
g
/
d
L
) *
0
0.2
0.4
0.6
0.8
1.0
1.2
ND HFD
S
e
r
u
m
 N
E
F
A
 
(
m
M
) *
0
10
20
30
40
50
60
ND HFD
S
e
r
u
m
 
T
r
i
g
l
y
c
e
r
i
d
e
 
(
m
g
/
d
L
)
S
e
r
u
m
 C
h
o
le
s
t
e
r
o
l
 
(
m
g
/d
l
)
0
50
100
150
200
250
ND HFD
**
B
180
0
100
200
300
400
500
600
0 30 60 90 120 150
Min after injection
B
l
o
o
d
 
g
l
u
c
o
s
e
 
(
m
g
/
d
L
)
WT
IKKε KO
**
**
* ND
0
100
200
300
400
500
600
0 30 60 90 120 150 180
Min after injection
B
l
o
o
d
 
g
l
u
c
o
s
e
 
(
m
g
/
d
L
)
WT
IKKε KO
**
*
** ** **
*
HFD
C
0 30 60 1800
1
2
3
ND KO
HFD KO
ND WT
HFD WT
time (min)
i
n
s
u
li
n
 
(
n
g
/
m
L
)
*
* * *
D
0
50
100
150
200
250
300
350
0 30 60 90 120
Min after injection
B
l
o
o
d
 
g
l
u
c
o
s
e
 
(
m
g
/
d
L
)
KO/ND
KO/HFD
WT/ND
WT/HFD
0
20
40
60
80
100
120
0 30 60 90 120
Min after injection
B
l
o
o
d
 g
lu
c
o
s
e
 (
%
 
b
a
s
a
l)
FE
0
50
100
150
200
250
300
0 30 60 90
Time after pyruvate injection (min)
B
l
o
o
d
 
g
l
u
c
o
s
e
 
(
m
g
/
d
L
)
WT-HFD
IKKε KO-HFD
**
**
**
0
500
1000
1500
2000
2500
3000
ND HFD
S
e
r
u
m
 i
n
s
u
l
in
 
(
p
g
/
m
l
)
*
Figure 4. IKK3 KO Mice Display Improved Glucose and Lipid Homeostasis
(A) Blood glucose and serum insulin levels measured for 18 hr fasting WT (gray bar) and KO (black bar) mice fed with ND or HFD as indicated. n = 12 mice per
group.
(B) SerumNEFA, triglyceride and total cholesterol levels measured for 18 hr-fastingWT (gray bar) and KO (black bar) mice fed with ND or HFD as indicated. n = 12
mice per group.
(C) Glucose tolerance test (GTT) measured for 12 hr-fasting WT (gray) and KO (black) mice fed with ND (left panel) or HFD (right panel). n = 12 mice per group.
(D) Serum insulin levels measured for mice during GTT shown in (C) at time points 0, 30, 60 and 180min after injection.
(E) Insulin tolerance test (ITT) measured for 3 hr fasting WT (gray) and KO (black) mice fed with ND or HFD. n = 12 mice per group.
(F) Pyruvate tolerance test (PTT) measured for 12 hr fasting WT (gray) and KO (black) mice fed with HFD. n = 12 mice per group. All data are presented as the
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Figure 5. IKK3 KO Preserves Insulin Signaling and Insulin Sensitivity in Liver and Adipose Cells in Mice on HFD
(A-C) Mice fasted for 18 hr were IP-injected with insulin (5 mU/g) or saline. Lysates from liver (A), WAT (B) and gastrocnemius (C) of WT, or IKK3 KOmice fed with
HFD were immunoblotted with indicated antibodies.
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While it is clear that obesity can induce inflammation in adipose
tissue, it is possible that inflammation occurs in liver as well
(Sanyal, 2005; Schwabe and Brenner, 2006). HFD increased
the mRNA levels of TNF-a, MCP-1, MIP-1a, Rantes and IP-10
in livers ofwild-typebut notKOmice (Figure 7E). iNOSexpression
was similarly elevated upon high-fat feeding of wild-type but not
KO mice (Figure 7F).
Because inflammation appeared to be reduced in IKK3 KO
mice, we assayed signaling pathways in liver, WAT and muscle
tissues thought to be associated with chronic inflammation. To
assess the role of the JNK pathway (Nakatani et al., 2004; Singh
et al., 2009; Solinas et al., 2007), we immunoblotted lysates from
wild-type and IKK3 KO mice with a phospho-JNK antibody, as
a surrogate to assay activation of the kinase. HFD produced
increased JNK phosphorylation in liver, gastrocnemius muscle,
and WAT (Figure 7G). Interestingly, IKK3 KO mice exhibited
reduced levels of JNKphosphorylation in all three tissues compa-
rable to control-fed wild-type mice. We observed similar results
regarding JNK phosphorylation in isolated adipocytes and cells
derived from the SVF, suggesting that loss of IKK3 reduces the
inflammatory response in both cell types (FigureS13A).However,
overexpression of IKK3 in 3T3-L1 adipocytes had no effect on
JNK phosphorylation, under conditions in which TNF-a activates
JNK (Figure S13B). In addition, knockdown of IKK3 in RAW cells
did not alter JNK phosphorylation in response to LPS (Fig-
ure S13C). These data suggest that the reduced activation of
this pathway in KO mice was likely to be secondary to reduced
fat accumulation, leading us to conclude that the JNK pathway
is not a direct target of IKK3. Moreover, the level of IkB in these
tissues was not changed by the loss of IKK3, confirming that
IKK3 does not appear to play a role in maintaining the stability
of IkB (Tenoever et al., 2007).
Taken together, these data suggest that targeted deletion
of the IKK3 gene prevents the generation of low-grade inflam-
mation in response to high-fat feeding. Because IKK3 can regu-
late expression of certain inflammatory genes, we wondered
whether IKK3 KO mice might be unresponsive to acute inflam-
matory signals as well. LPS injection stimulated both IKKb
and IkB phosphorylation in liver and WAT of both wild-type
and KO mice, and also led to a profound elevation in circulating
levels of MCP-1 and Rantes within 2.5 hr (Figure S14). The
levels of these cytokines were completely unchanged in IKK3
KO mice compared with wild-type controls, suggesting that
IKK3 is not involved in the acute immune response, but may
play a role in sustaining a state of chronic, low-grade inflamma-
tion in obesity.
DISCUSSION
A number of studies now suggest that obesity generates a state
of chronic, systemic low-grade inflammation (Hotamisligil, 2006;
Shoelson et al., 2007; Wellen and Hotamisligil, 2005). Numerous970 Cell 138, 961–975, September 4, 2009 ª2009 Elsevier Inc.genetic and pharmacological approaches indicate that the
NF-kB pathwaymay play a crucial role in this response, although
the tissues involved, the precise cell types that are activated in
those tissues, and the signaling processes remain uncertain.
To investigate the role of this pathway in obesity, we directly
examined NF-kB activation in vivo using HLL mice, a transgenic
line bearing the NF-kB-responsive promoter of HIV LTR fused to
luciferase (Sadikot et al., 2001). These studies revealed that HFD
activates NF-kB in fat and liver, with the most profound increase
in adipocytes and ATMs. The signals that lead to the activation of
NF-kB during high-fat feeding are unknown, as are the potential
consequences of sustained NF-kB activation in metabolic
tissues. We report here that the protein kinase IKK3, which is
induced by activation of the NF-kB pathway, might play a major
role as a mediator of this multifaceted process independent of
any role in acute immune responses.
IKK3 is a direct transcriptional target of the NF-kB pathway,
and is likely to amplify further inflammatory signals via phosphor-
ylation of other transcription factors. We show here that IKK3
gene and protein expression and enzyme activity are increased
in liver, adipocytes and ATMs after high-fat feeding, coincident
with the activation of NFkB. IKK3 KOmice are rendered resistant
to the deleterious effects of HFD on insulin sensitivity, exhibiting
normal glucose, pyruvate and insulin tolerance. Their circulating
cholesterol levels are markedly reduced, and adiponectin is
elevated while leptin is lowered. Interestingly, these mice do
not gain as much weight as wild-type mice on HFD, due to
increased energy expenditure. Additionally, these mice do not
develop hepatic steatosis, macrophage infiltration in adipose
tissue, or elevations in proinflammatory gene expression in fat
and liver expected with an inflammatory state.
These dramatic effects on glucose and lipid metabolism,
energy expenditure and inflammation beg an important ques-
tion, what is the primary effect of HFD-induced IKK3 elevation,
and where does it occur? Increased energy expenditure without
changes in RQ indicates that there is no shift in fuel substrate
preference in these animals. Although adiponectin levels were
elevated in KO mice, transgenic mice overexpressing adiponec-
tin at levels significantly higher than seen here do not phenocopy
the metabolic profile of IKK3 KO mice (Otabe et al., 2007), sug-
gesting that adiponectin alone is unlikely to account for the
phenotype. However, there was an elevation in UCP1 expression
in WAT, and IKK3 KO mice exhibited increased temperatures,
indicating that increased energy expenditure may be a result of
enhanced thermogenesis. The molecular mechanisms under-
lying this event are unknown, and could involve increased
expression or activity of PPARg (Kelly et al., 1998; Laplante
et al., 2003), or alleviation of a direct inhibitory effect of IKK3 on
the UCP1 promoter through phosphorylation of transcriptional
regulator(s). One interesting possibility is that IKK3 normally
functions to repress an adaptive increase in expression of
UCP1 in WAT in response to HFD.(I) Ex vivo insulin-stimulated glucose incorporation into lipid in adipocytes isolated from WT and KO mice fed with ND or HFD as indicated. Cells were untreated
(white bar) or treated with insulin for 60 min (shaded bar). n = 3 mice per condition. (**, p value < 0.01).
(J) Insulin-stimulated glucose uptake in 3T3-L1 adipocytes. Differentiated adipocytes were electroporated with vector control (white bar), IKK3WT (gray bar) or
IKK3 kinase dead (K38A) (black bar) mutant expression constructs. Cells were untreated (basal) or treated with insulin for 30min (Insulin). 14C-2DG uptake in cells
was normalized with total amount of protein. n = 3 for each condition. All data are presented as the average ± SEM.
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Figure 6. IKK3 KO Mice Are Protected from Diet-Induced Hepatic Steatosis
(A) Liver weight normalized with body weight was measured from WT (gray bar) and IKK3 KO (black bar) mice fed with ND or HFD as indicated. n = 8 for each
group. (*, p value < 0.05).
(B) Representative images of liver from WT and KO mice fed with ND or HFD as indicated.
(C) Liver triglyceride content normalized with liver weight was measured from WT (gray bar) and IKK3 KO (black bar) mice fed with ND or HFD in fed or fasted
condition as indicated. n = 8 for each group (*, p value < 0.05; **, p value < 0.01).
(D) Representative images of hematoxylin and eosin-stained section of liver from fastingWT or KOmice fed with HFD for 2 months. Arrows indicate central veins.
(E) (Top) qPCR analysis on the expression of the gene encoding Lipin1 in liver of WT and IKK3 KOmice fed with ND or HFD as indicated. Gray bars, wild-typemice
(n = 6); black bar, IKK3 KO mice (n = 6). (*, p value < 0.05). (Bottom) protein expression of lipin1 in liver, measured by immunoblotting with liver lysates from WT
(duplicate mice in each group) and IKK3 KO mice (triplicate mice in each group) fed with ND or HFD as indicated. Rab5 was used as an internal loading control.
(F) qPCR analysis on the expression of genes encoding CD36, FABP4, PPARg in liver of WT and IKK3 KOmice fed with ND or HFD as indicated. Gray bars, wild-
type mice (n = 6); black bar, IKK3 KO mice (n = 6). (*, p value < 0.05; **, p value < 0.01).Cell 138, 961–975, September 4, 2009 ª2009 Elsevier Inc. 971
It is possible that both metabolic and inflammatory changes in
the IKK3 KO mice are secondary to lower body weight. Weight
reduction would be expected to reduce macrophage infiltration
in adipose tissue and improve glucose and insulin tolerance.
However, this difference in energy expenditure was only seen
in HFD mice, and weight-matched animals showed the same
differences in rectal temperature, and inflammation (data not
shown), suggesting that weight loss alone is unlikely to explain
these traits. It is also possible that IKK3 gene deletion in macro-
phages prevents the initial inflammatory response to HFD,
subsequently leading to metabolic resistance to diet. Indeed,
many studies have shown that deletion of inflammatory genes
can restore global glucose and insulin tolerance. However, other
targeted gene disruptions that block adipose tissue inflamma-
tion not prevent weight gain from HFD (Kanda et al., 2006; Les-
niewski et al., 2007; Moller, 2000; Weisberg et al., 2006). While
blockade of adipose tissue inflammation alone may not explain
the entire phenotype, we cannot exclude the possibility that
simultaneously reducing inflammation in liver and fat can
produce these changes.
IKK3KOmice also exhibited gene expression changes that are
consistent with improved insulin sensitivity. In adipose tissue,
PPARgmRNA was increased, along with changes in genes (adi-
ponectin, CAP, CD36 and TNF-a) sensitive to PPARg activation.
Moreover, there was a significant reduction in adipocyte size,
along with an increase in cell number that is expected with
PPARg activation and increased adipogenesis (Okuno et al.,
1998; Tsuchida et al., 2005). At the same time, overexpression
of wild-type IKK3 produced a substantial reduction in insulin-
stimulated glucose uptake in 3T3-L1 adipocytes, indicating
that the IKK3-dependent insulin resistance in adipocytes might
be at least partially cell autonomous.
IKK3 KO also improved glucose and lipid metabolism in the
liver. In addition to the almost complete prevention of steatosis,
there were large reductions in circulating cholesterol. Transcrip-
tional profiling of IKK3KOmice revealed reduced levels of PDK4,
PPARg, FABP4 and CD36 mRNA, with increases in PPARa,
lipin1 and glucokinase, all of which are consistent with enhanced
insulin sensitivity and decreased lipid synthesis and export.
These genes may be regulated by transcription factors that are
direct targets of IKK3. In this regard, overexpression of IKK3 in
hepatoma cells increased expression of selected gluconeo-
genic, lipogenic and proinflammatory genes, indicating that at
least some of these effects were direct and cell autonomous in
the liver.
We are currently investigating the kinase substrates of IKK3 in
tissues that respond to HFD. We hypothesize that some of these
targets may be transcriptional activators or repressors that regu-
late metabolic genes. A number of the genes that changed in
IKK3 KO mice in both liver and fat are transcriptionally regulated
by interferon regulatory factor (IRF) family members in 3T3-L1
adipocytes (Eguchi et al., 2008), although the mechanism(s) by
which IRF3 acts as a repressor remains unknown. Additionally,972 Cell 138, 961–975, September 4, 2009 ª2009 Elsevier Inc.IKK3 can catalyze STAT1 phosphorylation on serine 708 in
response to interferon b treatment in vitro (Tenoever et al.,
2007). Phosphorylation of S708 favors the formation of STAT1/
STAT2 heterodimers for assembly of the ISGF3 (interferon-
stimulated gene factor 3) complex. This complex binds to inter-
feron-stimulated response elements in the promoters of inter-
feron-stimulated genes, some of which, including IFI205, IFIT2,
and IFIT3, were identified in the microarray analyses, and thus
might lie downstream of this pathway.
The increased expression of IKK3 in liver, adipocytes and
ATMs, coupled with the complex nature of the IKK3 KO pheno-
type, suggest that IKK3 is likely to exert its effects through all
three tissues in a manner that involves crosstalk among these
cells. Although IKK3 is unlikely to play a role in the initial inflam-
matory response to high-fat feeding, it may be required for a sus-
tained inflammatory state. Although it is important to note that
IKK3 KO mice are susceptible to lethal viral infections (Tenoever
et al., 2007), the specificity of the apparent actions of IKK3, the
nature of the enzyme, and the profound resistance of KO mice
to high-fat diet, make it an especially appealing drug target for
the treatment of metabolic disease.
EXPERIMENTAL PROCEDURES
See Supplemental Data for details.
Immunohistochemistry and Confocal Microscopy
IHC and confocal microscopy were performed as described (Lumeng et al.,
2007a; Lumeng et al., 2008). Adipocyte cross-sectional area from caveolin
stained adipose tissue images (150-200 adipocytes/mouse, 3 mice/genotype)
was calculated using CellProfiler image analysis software. Adipocyte number
was calculated from adipocyte diameters using established formulas (Hirsch
and Batchelor, 1976).
In Vitro IKK3 Kinase Assay in Cos Cells
Cos cells were transfected with plasmid encoding FLAG-IKK3 for 24 h and
treated with LPS (1 mg/ml) for 30min before harvested. FLAG-IKK3 in whole
cell lysates was immunoprecipitated and subjected to an in vitro kinase assay
usingMBP as substrate. Following fractionation of samples by SDS-PAGE, the
[r-32P]-ATP-labeled MBP on the lower half of the gel was quantified by autora-
diography; the upper half of gel was blotted for the immunoprecipitated kinase
using anti-FLAG antibody.
SUPPLEMENTAL DATA
Supplemental Data include fourteen figures, four tables, Supplemental Exper-
imental Procedures, and Supplemental References and can be found with this
article online at http://www.cell.com/supplemental/S0092-8674(09)00793-4.
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Figure 7. Obesity-Induced Inflammation Is Attenuated in IKK3 KO Mice
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